Despite the impressive results of autologous CAR-T cell therapy in refractory B
lymphoproliferative diseases, CAR-NK immunotherapy emerges as a safer, faster, and cost …

Over the past few years, cellular immunotherapy has emerged as a novel treatment option
for certain forms of hematologic malignancies with multiple CAR-T therapies now routinely …

Natural Killer (NK) cells are critical members of the innate immunity lymphocytes and have a
critical role in host defense against malignant cells. Adoptive cell therapy (ACT) using …

Natural killer (NK) cells, a unique component of the innate immune system, are inherent
killers of stressed and transformed cells. Based on their potent capacity to kill cancer cells …

Genome engineered natural killer (NK) cell therapies are emerging as a promising cancer
immunotherapy platform with potential advantages and remaining uncertainties. Feeder …

Antitumor activity of immune cells such as T cells and NK cells has made them auspicious
therapeutic regimens for adaptive cancer immunotherapy. Enhancing their cytotoxic effects …

Natural killer (NK) cell therapies, primarily based on chimeric antigen receptor NK cells
(CAR‐NK), have been developed and applied clinically for therapeutic treatment of patients …

Adoptive cell treatment (ACT) utilizing chimeric antigen receptors (CAR) diverts the
specificity of safe cells against a target-specific antigen and portrays exceptional potential for …

Natural killer (NK) cells are prominent cytotoxic and cytokine-producing components of the
innate immune system representing crucial effector cells in cancer immunotherapy …

Natural killer (NK) cells are a subset of cytotoxic lymphocytes within the innate immune
system. While they are naturally cytotoxic, genetic modifications can enhance their tumor …